AI
Subtle Medical | October 06, 2021
HALO Diagnostics (formerly Desert Medical Imaging), a leading medical imaging provider headquartered in Southern California, announced today a partnership with Subtle Medical, a healthcare technology company focused on AI-powered software solutions that enable faster, safer, and smarter medical imaging. HALO has implemented both SubtleMR™ and SubtlePET™ image enhancement software at multiple locations, leading to higher quality imaging and improved patient experience.
"With Subtle's technology, we now have the ability to restore image quality to standard of care when conducting shorter scan times for MRI and PET and lower dose PET exams. This combination allows us to better tailor scans to patient needs and improve workflow efficiency, patient experience, and patient safety. The addition of Subtle Medical's technology to HALO Diagnostics furthers our commitment to precision focused, personalized healthcare."
MD, Chief Medical Officer at HALO Diagnostics
HALO Diagnostics is focused on saving and extending the quality of people's lives through the early detection of the leading causes of death with precision diagnostics. Combining leaders from the medical, scientific and high technology communities, HALO Diagnostics is a leader in the early detection of cancer's like Prostate and Breast in men and women.
"We could not be more pleased that Halo Diagnostics has adopted both SubtleMR and SubtlePET. Our unique technology not only supports a better patient experience from less time in the imaging suite, but also increased perceived safety. We look forward to a long partnership with Halo".
Chief Commercial Officer for Subtle Medical
Subtle Medical has an extensive product pipeline. The company's technologies utilize proprietary deep learning algorithms that integrate seamlessly with any OEM scanner to improve image quality from accelerated image acquisition without any alteration in the imaging specialists' workflow.
About HALO
HALO Diagnostics (HALO Dx, Inc.) changes patient lives and outcomes through early detection of the leading causes of death with precision diagnostics. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale combined with deep learning algorithms. By optimizing all these solutions under the HALO Diagnostics platform, we provide rapid, precise, actionable results to enable life-changing treatments by physicians for their patients.
About Subtle Medical
Subtle Medical, Inc. is an innovative healthcare technology company with a suite of software solutions that use deep learning to increase the quality and efficiency of medical imaging. Subtle's software solutions are integrated at hospitals and imaging institutions worldwide. It was named a CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.
Read More
AI
i2i Population Health | February 17, 2022
i2i Population Health has made a great stride in providing on-going, unparalleled support for its customers by entering into a partnership agreement with HealthTalk A.I., a leading patient engagement company.
i2i's powerful population health solution in collaboration with HealthTalk A.I.'s best-in-class patient engagement solution will support FQHC's efforts to serve under-served populations and drive quality care. This alliance will equip care teams with the best tools on the market to find and engage the patients who might otherwise slip through the cracks. FQHCs will be able to use i2i and HealthTalk A.I.'s toolsto identify high-risk patients, efficiently connect with them, and in turn, close care gaps and improve care quality.
This partnership equips FQHCs likePennsylvania-based Neighborhood Health Centers of theLehigh Valley(NHCLV) with the ability to send targeted campaigns directly from the i2i platform.
"With HealthTalk A.I. and i2i now working together, our care teams will be set up to achieve much greater efficiency," saidMelissa Miranda, RN, CEO at NHCLV. "Not only does this support our population health initiatives, but itgives our care teams more options for engaging with all patients while at the same time delivering quality clinical care and building trust with the at-risk patients we serve."
"We are excited about this partnership with HealthTalk A.I., a company whose values and solutions align seamlessly with our mission to serve others for healthier communities."
i2i Population Health CEO,Justin Neece
About HealthTalk A.I.
HealthTalk A.I. helps healthcare providers improve access to care and intervene like never before possible. Their fully-automated, text-based platform delivers user-friendly communication with specificmessages and rules dictated by each healthcare organization. This gives providers the ability to engage 100% of theirpopulation and close the loop with customer recovery actions and clinical encounters.
About i2i Population Health
i2i is the nation's largest population health technology company serving the underserved, safety net market with 20 years of experience spanning 37 states and 30 million lives. The i2i platform powers an advanced data integration and aggregation engine that publishes normalized clinical and administrative data through unique quality management and care coordination applications. Driving improved outcomes in quality program performance is a core competency of i2i.
Read More
FUTURE OF HEALTHCARE
DocGo | May 06, 2022
DocGo has signed a contract with Empire BlueCross BlueShield to provide mobile health services to Empire BlueCross BlueShield members in New York and New Jersey. DocGo is a major last-mile mobile health service company that has offered integrated medical transportation solutions to various other healthcare service companies and organizations.
DocGo operates in 28 U.S. states and the United Kingdom, providing Mobile Health services at scale. The services are solely dedicated to governmental entities, hospital networks, and enterprise customers to provide high-quality, low-cost care to patients.
Empire, an Anthem, Inc.-affiliated health plan, is New York's largest health insurer and has been serving residents for more than 85 years. DocGo now will reach an additional 4.5 million people with its in-home mobile health services. The services include urgent episodic care, preventative care, and chronic care management.
The contract, which goes into effect on June 1, 2022, will allow DocGo to provide access to high-quality healthcare facilities to more people. DocGo aligns with Empire's primary mission of materially and measurably improving the health of all New Yorkers. DocGo brings care solutions to patients when and where they need them most, particularly in their homes.
"Expanding the reach of our mobile health services and virtual-first offerings is a clear demonstration of our continued growth and momentum for millions of new people in New York. We are excited to assist in making quality healthcare more convenient and accessible to even more patients."
On this new venture, DocGo President Anthony Capone
About the contract, Jordan Vidor, RVP, Provider Solutions and Network Strategy, Empire BlueCross BlueShield, also shares that "As part of our mission to improve New Yorkers' health, we will continue to prioritize solutions that meet the need for safe, convenient, high-quality, and affordable care. Our new partnership with DocGo will enable us to make it easier for New Yorkers to find and access care from the comfort of their own homes if and when they require it.”
Read More